s-Triazine compounds, pharmaceutical compositions and methods of using the same
AssigneeNew York University
InventorNeville Robert Kallenbach
Life of this patent
Estimating the term…
Abstract
Novel s-triazine compounds are disclosed that have a formula represented by the following: L1, L2, L3, R1, R2, R3, R4, R5a, R5b, and R5c are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, where microbial infection is either a direct cause or a related condition.
Claims25
A s-triazine compound having a formula:
- wherein
- L1 is a single bond, and L2 is C1-C4 alkylene;
- or
- L1 is C1-C4 alkylene, and L2 is a single bond or C1-C4 alkylene;
- L3 is selected from C2-C6 alkylene, C2-C6 alkenyl, and C2-C6 alkynyl;
- each of R1 and R2 is independently substituted or unsubstituted C1-C6 alkyl;
- or
- R1 and R2 may join together to form a 4-7 membered heterocycloalkyl;
- or
- R1 is H;
- and R2 is —C(═NH)—NH2;
- R3 is R4;
- or R3 is selected from substituted or unsubstituted aryl and substituted or unsubstituted heteroaryl;
- R4 is substituted or unsubstituted
- each X is C or N;
- provided that no more than three Xs are N at one time;
- and
- the X through which the R4 is attached to L1 or L2 is C;
- each Y is C or N;
- provided that no more than three Ys are N at one time;
- and
- the Y through which the R4 is attached to L1 or L2 is C;
- R6 is H or substituted or unsubstituted C1-C6 alkyl;
- each R5a, R5b, or R5c is independently H or substituted or unsubstituted C1-C6 alkyl;
- or a pharmaceutically acceptable salt thereof;
- or stereoisomers, or tautomers thereof.
A pharmaceutically acceptable salt of a compound according to formula IXa, or TN-3:
- or a stereoisomer, or a tautomer thereof.
A pharmaceutically acceptable salt of a compound according to formula IXc, Xa, or TN-5:
- or a stereoisomer, or a tautomer thereof.
Dependencies are inferred from the claim text.